相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89Zr-immuno-PET
Danielle J. Vugts et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
The 68Ga/177Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUVmax values and absorbed dose estimates
Lorenza Scarpa et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Zirconium tetraazamacrocycle complexes display extraordinary stability and provide a new strategy for zirconium-89-based radiopharmaceutical development
Darpan N. Pandya et al.
CHEMICAL SCIENCE (2017)
An Eighteen-Membered Macrocyclic Ligand for Actinium-225 Targeted Alpha Therapy
Nikki A. Thiele et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
AAZTA: An Ideal Chelating Agent for the Development of 44Sc PET Imaging Agents
Gabor Nagy et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
New Tris(hydroxypyridinone) Bifunctional Chelators Containing Isothiocyanate Groups Provide a Versatile Platform for Rapid One Step Labeling and PET Imaging with 68Ga3+
Michelle T. Ma et al.
BIOCONJUGATE CHEMISTRY (2016)
Imaging quality of 44Sc in comparison with five other PET radionuclides using Derenzo phantoms and preclinical PET
Maruta Bunka et al.
APPLIED RADIATION AND ISOTOPES (2016)
Current advances in ligand design for inorganic positron emission tomography tracers 68Ga, 64Cu, 89Zr and 44Sc
Thomas W. Price et al.
DALTON TRANSACTIONS (2016)
Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancer
Martin Barrio et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2016)
Dose Deposits from 90Y, 177Lu, 111In, and 161Tb in Micrometastases of Various Sizes: Implications for Radiopharmaceutical Therapy
Elif Hindie et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy
Richard P. Baum et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
225Ac-PSMA-617 for PSMA-Targeted a-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer
Clemens Kratochwil et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Comparison between Three Promising β-emitting Radionuclides, 67Cu, 47Sc and 161Tb, with Emphasis on Doses Delivered to Minimal Residual Disease
Christophe Champion et al.
THERANOSTICS (2016)
Preclinical in vivo application of 152Tb-DOTANOC: a radiolanthanide for PET imaging
Cristina Muller et al.
EJNMMI RESEARCH (2016)
Physics of pure and non-pure positron emitters for PET: a review and a discussion
Maurizio Conti et al.
EJNMMI PHYSICS (2016)
DATATOC: a novel conjugate for kit-type 68Ga labelling of TOC at ambient temperature
Johanna Seemann et al.
EJNMMI RADIOPHARMACY AND CHEMISTRY (2016)
Separation of cyclotron-produced 44Sc from a natural calcium target using a dipentyl pentylphosphonate functionalized extraction resin
H. F. Valdovinos et al.
APPLIED RADIATION AND ISOTOPES (2015)
Time to demand dosimetry for molecular radiotherapy?
D. R. McGowan et al.
BRITISH JOURNAL OF RADIOLOGY (2015)
A shortcut to high-affinity Ga-68 and Cu-64 radiopharmaceuticals: one-pot click chemistry trimerisation on the TRAP platform
Zsolt Baranyai et al.
DALTON TRANSACTIONS (2015)
Cu(I)-assisted click chemistry strategy for conjugation of non-protected cross-bridged macrocyclic chelators to tumour-targeting peptides
Zhengxin Cai et al.
DALTON TRANSACTIONS (2015)
Fusarinine C, a novel siderophore-based bifunctional chelator for radiolabeling with Gallium-68
Chuangyan Zhai et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2015)
Preclinical Evaluation of 86Y-Labeled Inhibitors of Prostate Specific Membrane Antigen for Dosimetry Estimates
Sangeeta Ray Banerjee et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies
Martina Weineisen et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Cyclotron production of high purity 44m,44Sc with deuterons from 44CaCO3 targets
C. Alliot et al.
NUCLEAR MEDICINE AND BIOLOGY (2015)
Cyclotron production of 44Sc: From bench to bedside
Nicholas P. van der Meulen et al.
NUCLEAR MEDICINE AND BIOLOGY (2015)
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors
Lisa Bodei et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Cyclotron production of 43Sc for PET imaging
Rafal Walczak et al.
EJNMMI PHYSICS (2015)
Rational Design, Synthesis, and Evaluation of Tetrahydroxamic Acid Chelators for Stable Complexation of Zirconium( IV)
Francois Guerard et al.
CHEMISTRY-A EUROPEAN JOURNAL (2014)
Phosphinic Acid Functionalized Polyazacycloalkane Chelators for Radiodiagnostics and Radiotherapeutics: Unique Characteristics and Applications
Johannes Notni et al.
CHEMMEDCHEM (2014)
Direct in vitro and in vivo comparison of 161Tb and 177Lu using a tumour-targeting folate conjugate
Cristina Mueller et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Alternative Chelator for 89Zr Radiopharmaceuticals: Radiolabeling and Evaluation of 3,4,3-(LI-1,2-HOPO)
Melissa A. Deri et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Promising Prospects for 44Sc-/47Sc-Based Theragnostics: Application of 47Sc for Radionuclide Tumor Therapy in Mice
Cristina Mueller et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Tailored Gallium(III) Chelator NOPO: Synthesis, Characterization, Bioconjugation, and Application in Preclinical Ga-68-PET Imaging
Jakub Simecek et al.
MOLECULAR PHARMACEUTICS (2014)
44Sc: An Attractive Isotope for Peptide-Based PET Imaging
Reinier Hernandez et al.
MOLECULAR PHARMACEUTICS (2014)
44gSC production using a water target on a 13 MeV cyclotron
Cornelia Hoehr et al.
NUCLEAR MEDICINE AND BIOLOGY (2014)
Past, present and future of 68Ge/68Ga generators
F. Roesch
APPLIED RADIATION AND ISOTOPES (2013)
The ubiquitous DOTA and its derivatives: the impact of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid on biomedical imaging
Graeme J. Stasiuk et al.
CHEMICAL COMMUNICATIONS (2013)
Radiometals for Combined Imaging and Therapy
Cathy S. Cutler et al.
CHEMICAL REVIEWS (2013)
PSMA as a target for radiolabelled small molecules
Matthias Eder et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
89Zr, a Radiometal Nuclide with High Potential for Molecular Imaging with PET: Chemistry, Applications and Remaining Challenges
Gabriel Fischer et al.
MOLECULES (2013)
PET imaging with 89Zr: From radiochemistry to the clinic
Melissa A. Deri et al.
NUCLEAR MEDICINE AND BIOLOGY (2013)
68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
Matthias Eder et al.
BIOCONJUGATE CHEMISTRY (2012)
Copper-64 labelling of triazacyclononane-triphosphinate chelators
Jakub Simecek et al.
DALTON TRANSACTIONS (2012)
THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience
Richard P. Baum et al.
THERANOSTICS (2012)
Maturation of a Key Resource - The Germanium-68/Gallium-68 Generator: Development and New Insights
F. Roesch
CURRENT RADIOPHARMACEUTICALS (2012)
Bismuth-213 and Actinium-225 - Generator Performance and Evolving Therapeutic Applications of Two Generator-Derived Alpha-Emitting Radioisotopes
Alfred Morgenstern et al.
CURRENT RADIOPHARMACEUTICALS (2012)
Matched pairs dosimetry: 124I/131I metaiodobenzylguanidine and 124I/131I and 86Y/90Y antibodies
Egesta Lopci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
89Zr Radiochemistry for Positron Emission Tomography
Gregory W. Severin et al.
Medicinal Chemistry (2011)
86Y Based PET Radiopharmaceuticals: Radiochemistry and Biological Applications
Tapan K. Nayak et al.
Medicinal Chemistry (2011)
The low-energy β- and electron emitter 161Tb as an alternative to 177Lu for targeted radionuclide therapy
Silvia Lehenberger et al.
NUCLEAR MEDICINE AND BIOLOGY (2011)
Actinium-225 in Targeted Alpha-Particle Therapeutic Applications
David A. Scheinberg et al.
CURRENT RADIOPHARMACEUTICALS (2011)
Targeted Alpha Therapy with Bi-213
Alfred Morgenstern et al.
CURRENT RADIOPHARMACEUTICALS (2011)
Technetium and Gallium Derived Radiopharmaceuticals: Comparing and Contrasting the Chemistry of Two Important Radiometals for the Molecular Imaging Era
Mark D. Bartholomae et al.
CHEMICAL REVIEWS (2010)
Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
Dik J. Kwekkeboom et al.
ENDOCRINE-RELATED CANCER (2010)
A Ti-44/Sc-44 radionuclide generator for potential application of Sc-44-based PET-radiopharmaceuticals
D. V. Filosofov et al.
RADIOCHIMICA ACTA (2010)
Copper-64 Radiopharmaceuticals for PET Imaging of Cancer: Advances in Preclinical and Clinical Research
Carolyn J. Anderson et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2009)
Synthesis of a novel bifunctional chelator AmBaSar based on sarcophagine for peptide conjugation and 64Cu radiolabelling
Hancheng Cai et al.
DALTON TRANSACTIONS (2009)
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE:: the role of associated risk factors
Lisa Bodei et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Tetrafluorophenolate of HBED-CC:: a versatile conjugation agent for 68Ga-labeled small recombinant antibodies
Matthias Eder et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
The Impact of PET and SPECT on Dosimetry for Targeted Radionuclide Therapy
Glenn Flux et al.
ZEITSCHRIFT FUR MEDIZINISCHE PHYSIK (2006)
In vivo evaluation of 177Lu- and 67/64Cu-labelled recombinant fragments of antibody chCE7 for radioimmunotherapy and PET imaging of L1-CAM-positive tumors
J Grünberg et al.
CLINICAL CANCER RESEARCH (2005)
Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3] octreotate in patients with endocrine gastroenteropancreatic tumors
DJ Kwekkeboom et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Radiolabelling DOTA-peptides with 68Ga
WAP Breeman et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Positron flight in human tissues and its influence on PET image spatial resolution
A Sanchez-Crespo et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
Copper-67 as a therapeutic nuclide for radioimmunotherapy
I Novak-Hofer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2002)
Production routes of the alpha emitting Tb-149 for medical application
GJ Beyer et al.
RADIOCHIMICA ACTA (2002)
Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC:: preliminary data
M Hofmann et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2001)
Tumor therapy with targeted atomic nanogenerators
MR McDevitt et al.
SCIENCE (2001)
Dosimetric comparison of radionuclides for therapy of somatostatin receptor-expressing tumors
P Bernhardt et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
[177Lu-DOTA0,Tyr3]octreotate:: comparison with [111In-DTPA0]octreotide in patients
DJ Kwekkeboom et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2001)
分享论文
